Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.43%||166.86||0.7%||$1081.06m|
|LLY||Eli Lilly & Co.||0.04%||316.96||1.1%||$820.24m|
|MRK||Merck & Co., Inc.||0.42%||91.42||0.7%||$782.30m|
|BMY||Bristol-Myers Squibb Co.||-0.55%||74.15||1.0%||$614.48m|
|SIGA||SIGA Technologies, Inc.||-6.42%||23.18||0.0%||$439.36m|
|GBT||Global Blood Therapeutics, Inc.||0.08%||67.05||5.6%||$352.06m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.14%||223.45||8.2%||$270.68m|
|HZNP||Horizon Therapeutics Plc||-0.84%||61.21||5.4%||$225.68m|
|KRTX||Karuna Therapeutics, Inc.||-0.08%||261.01||0.0%||$204.69m|
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.